Normal QTc by Age
The QT interval is significantly heart rate-dependent. A bradycardic infant will naturally have a longer QT interval than a tachycardic one. For this reason, pediatric cardiologists abandoned adult cutoffs many decades ago.
In pediatric practice, QTc >460 ms is generally considered prolonged regardless of age. Some key considerations:
- Neonates (first week): QTc up to 460 ms may be normal; values >470 ms warrant investigation.
- Infants and children: QTc >450 ms is borderline; >460 ms is prolonged.
- Adolescents: QTc >460 ms in males and >470 ms in females is prolonged (post-pubertal sex differences emerge).
Girls typically have longer QTc intervals after puberty. Any QTc >500 ms carries substantial risk for torsades de pointes and requires urgent evaluation. QTc 460–500 ms warrants monitoring, especially when combined with QTc-prolonging medications or electrolyte abnormalities.
Kids on QTc-prolonging drugs or with family histories of sudden death? Serial ECGs every few months is standard practice.
Bazett vs Fridericia
Clinically, the Bazett formula (QTc = QT ÷ √RR) is most commonly used because it is widely available and matches most reference data. However, it has known limitations: it overcorrects at high heart rates and undercorrects at low heart rates, reducing accuracy in tachycardic infants or bradycardic older children.
The Fridericia formula (QTc = QT ÷ ³√RR) performs better at heart rate extremes, and emerging evidence supports its superiority. If the Bazett-corrected QTc is borderline or the heart rate is significantly abnormal, calculating Fridericia may provide additional clarity.
Use QTc Calculator to compute both values.
Congenital Long QT Syndrome
Long QT syndrome (LQTS) is an inherited channelopathy, mutations in ion channels mess up repolarization. Potassium and sodium channel variants account for most cases.
The clinical phenotypes matter more than the genetic label:
- LQT1 (~40–45%): Most common. Exercise (especially swimming) and emotional stress trigger arrhythmias.
- LQT2 (~25–30%): Sudden auditory stimuli (alarm clocks, phone ringing) or emotional stress can precipitate events.
- LQT3 (~5–10%): Events typically occur at rest or during sleep, often bradycardia-dependent.
- LQT4–17: Rare, variable phenotypes.
A kid with QTc >460 ms, syncope, and family history of sudden death? That's LQTS until proven otherwise, get them to cardiology and do genetic testing.
Beta-blockers work great for LQT1 and LQT2. LQT3 patients often need sodium channel blockers like mexiletine instead. ICDs for the high-risk ones or those who keep breaking through medical therapy.
Acquired QTc Prolongation
Acquired QTc prolongation is way more common than congenital LQTS in the clinic. And you cause it a lot, medications, electrolyte shifts, systemic illness.
The usual suspects:
- Antiarrhythmics: sotalol, amiodarone, flecainide
- Antipsychotics: haloperidol, risperidone, clozapine
- Antibiotics: macrolides (azithromycin especially), fluoroquinolones
- Antiemetics: domperidone, metoclopramide
- Antiretrovirals: protease inhibitors, integrase inhibitors
Electrolyte abnormalities are particularly important: hypokalemia, hypocalcemia, and hypomagnesemia substantially amplify drug-induced QTc risk. These factors combine to significantly increase the risk of torsades de pointes, especially in female patients, those with myocarditis, or bradycardic children.
Always grab a baseline QTc before starting high-risk drugs. Then recheck at steady state. If electrolytes dip or you add another QTc drug? Another ECG makes sense.
Management Approach
When asymptomatic QTc prolongation is identified, determine whether it represents a congenital channelopathy or drug-related effect. Serial ECGs performed every 2-4 weeks assess for progression. If long QT syndrome is suspected, family screening is indicated.
Children with symptomatic presentations (syncope or significant family history of sudden death) require urgent pediatric cardiology evaluation. These patients need genetic testing, exercise stress testing, and possibly continuous cardiac monitoring. Competitive sports participation should be restricted pending full evaluation.
Hospitalized children requiring QTc-prolonging medications require careful management. Correct any electrolyte abnormalities; hypokalemia combined with QTc drugs significantly increases arrhythmia risk. Avoid concurrent QTc-prolonging agents when possible. Obtain a baseline ECG before initiating therapy and repeat at days 2-5. If QTc exceeds 500 ms or increases more than 60 ms from baseline, discontinue the drug unless it is essential for survival.
Use QTc Calculator to automate this instead of eyeballing intervals.
Summary
QTc prolongation management requires age-appropriate interpretation of intervals, rigorous electrolyte monitoring, and careful determination of whether the prolongation is iatrogenic (and potentially reversible) or represents an inherited channelopathy (requiring long-term management). Early recognition and appropriate intervention prevent sudden cardiac death.